Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Tofacitinib may help treat severe hair loss, but more research is needed.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

More inflammation leads to faster and worse hair loss in women with frontal fibrosing alopecia.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Finasteride helps reduce pain and inflammation in animals.

Finasteride reduces movement issues in Parkinson's disease rats.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.